vimarsana.com

Latest Breaking News On - Davidp tusa - Page 1 : vimarsana.com

$16 44 Million in Sales Expected for Sharps Compliance Corp (NASDAQ:SMED) This Quarter

Equities research analysts expect Sharps Compliance Corp. (NASDAQ:SMED – Get Rating) to post $16.44 million in sales for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Sharps Compliance’s earnings. The highest sales estimate is $17.81 million and the lowest is $15.60 million. Sharps Compliance reported sales of $18.73 million during […]

Sharps Compliance Corp (NASDAQ:SMED) Given Consensus Rating of Hold by Analysts

Shares of Sharps Compliance Corp. (NASDAQ:SMED – Get Rating) have earned an average recommendation of “Hold” from the six ratings firms that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating and four have issued a hold rating on the company. The average 12 month […]

Pat Mulloy Appointed Chief Executive Officer of Sharps Compliance; Will Succeed David P Tusa

Sharps Compliance Reports Fiscal 2021 Third Quarter Results

Sharps Compliance Reports Fiscal 2021 Third Quarter Results
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Sharps Compliance Reports Fiscal 2021 Second Quarter Results

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Sharps Compliance Reports Fiscal 2021 Second Quarter Results Sharps Compliance Corp.January 28, 2021 GMT Second Quarter Revenue of $17.0 million, increased 17% from the prior year Second Quarter Customer Billings of $18.5 million, increased 24% over the prior year Retail market billings increased 46%; Long-Term Care market billings increased 56%; Pharmaceutical Manufacturer market billings grew 35% Route-Based Pickup billings increased 41% for the quarter Second Quarter Net Income of $0.07 per share Company now expects approximately $15 Million in COVID-19 related advance mailback orders in the March quarter, up from previous expectation of $10 million Robust COVID-19 related mailback order activity; Playing a key role in COVID-19 vaccine programs in Retail and Long-Term Care Settings

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.